AR095020A1 - Condón - Google Patents
CondónInfo
- Publication number
- AR095020A1 AR095020A1 ARP140100718A ARP140100718A AR095020A1 AR 095020 A1 AR095020 A1 AR 095020A1 AR P140100718 A ARP140100718 A AR P140100718A AR P140100718 A ARP140100718 A AR P140100718A AR 095020 A1 AR095020 A1 AR 095020A1
- Authority
- AR
- Argentina
- Prior art keywords
- condom
- condoms
- water
- neutralizing
- immersed
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 229960003711 glyceryl trinitrate Drugs 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000003472 neutralizing effect Effects 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000010410 dusting Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/02—Contraceptive devices; Pessaries; Applicators therefor for use by males
- A61F6/04—Condoms, sheaths or the like, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D3/00—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
- B05D3/002—Pretreatement
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee un condón que tiene un recubrimiento o depósito de una composición que incluye un agente fisiológicamente activo tal como gliceril trinitrato, donde el condón ha sido tratado con un material neutralizante o ácido de modo tal que el condón, cuando es sumergido en agua, logra que el agua tenga un pH de 7 o menos. El condón puede tratarse con una suspensión ácida de polvo para espolvoreo. Además se provee un proceso para la fabricación de condones, donde el proceso incluye las etapas de: 1) el tratamiento de los condones formados con un material neutralizante o ácido; y 2) a continuación, la aplicación a los condones, de una composición que incluye un agente fisiológicamente activo tal como gliceril trinitrato, donde los condones, cuando son sumergidos en agua, logran que el agua tenga un pH de 7 o menos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1303796.5A GB201303796D0 (en) | 2013-03-04 | 2013-03-04 | Condom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095020A1 true AR095020A1 (es) | 2015-09-16 |
Family
ID=48142346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140100718A AR095020A1 (es) | 2013-03-04 | 2014-03-05 | Condón |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10004712B2 (es) |
| EP (1) | EP2964191A1 (es) |
| JP (1) | JP6337027B2 (es) |
| KR (1) | KR20150138217A (es) |
| CN (1) | CN105188665A (es) |
| AR (1) | AR095020A1 (es) |
| AU (1) | AU2014224449B2 (es) |
| BR (1) | BR112015021306A2 (es) |
| CA (1) | CA2903289A1 (es) |
| GB (1) | GB201303796D0 (es) |
| MX (1) | MX2015011394A (es) |
| RU (1) | RU2668527C2 (es) |
| TW (1) | TW201440747A (es) |
| WO (1) | WO2014135855A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9904508B1 (en) * | 2016-09-27 | 2018-02-27 | Bose Corporation | Method for changing type of streamed content for an audio system |
| CN110467741A (zh) | 2018-04-20 | 2019-11-19 | 中科艾玛科技成都有限公司 | 一种亲水超滑的避孕套 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5482053A (en) * | 1989-06-06 | 1996-01-09 | Kelly; Patrick D. | Condom lubricants containing zinc as an anti-viral agent |
| US5980477A (en) * | 1991-07-29 | 1999-11-09 | Patrick Kelly | Genital lubricants with zinc salts as anti-viral additives |
| JP2002165822A (ja) | 2000-12-04 | 2002-06-11 | Sagami Gomme Kogyo Kk | 潤滑剤組成物及び同組成物を塗布したコンドーム（２） |
| WO2002078580A1 (en) | 2001-03-30 | 2002-10-10 | Futura Medical Developments Limited | Condom with an erectogenic composition |
| GB0208704D0 (en) * | 2002-04-16 | 2002-05-29 | Futura Medical Dev Ltd | Condom |
| US20050076917A1 (en) * | 2003-10-10 | 2005-04-14 | Biofilm Ip, Llc. | Lubricated condom |
| EP1576880A1 (en) * | 2004-03-16 | 2005-09-21 | Well-being Biochemical Corp. | Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use |
| WO2006049627A1 (en) * | 2004-11-02 | 2006-05-11 | Biofilm Ip, Llc | Lubricated condom |
| US20090197946A1 (en) * | 2008-01-31 | 2009-08-06 | Joseph Di Bartolomeo | Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases |
| US8087412B2 (en) * | 2008-05-01 | 2012-01-03 | Ansell Healthcare Products Llc | Dip-formed synthetic polyisoprene latex articles with improved intraparticle and interparticle crosslinks |
| CN202619949U (zh) * | 2011-10-19 | 2012-12-26 | 北京东方神起科技发展有限公司 | 一种ph值中性润滑层的安全套 |
| WO2014020613A1 (en) * | 2012-07-30 | 2014-02-06 | Plantus Health Supplements Private Limited | Probiotic layered condom |
| CN103405594A (zh) * | 2013-05-30 | 2013-11-27 | 石杰克 | 水溶性人体润滑剂及其制备方法和采用该润滑剂的安全套 |
-
2013
- 2013-03-04 GB GBGB1303796.5A patent/GB201303796D0/en not_active Ceased
-
2014
- 2014-03-04 JP JP2015560764A patent/JP6337027B2/ja not_active Expired - Fee Related
- 2014-03-04 AU AU2014224449A patent/AU2014224449B2/en not_active Ceased
- 2014-03-04 WO PCT/GB2014/050629 patent/WO2014135855A1/en active Application Filing
- 2014-03-04 CN CN201480024709.3A patent/CN105188665A/zh active Pending
- 2014-03-04 BR BR112015021306A patent/BR112015021306A2/pt not_active IP Right Cessation
- 2014-03-04 MX MX2015011394A patent/MX2015011394A/es unknown
- 2014-03-04 CA CA2903289A patent/CA2903289A1/en not_active Abandoned
- 2014-03-04 RU RU2015138950A patent/RU2668527C2/ru not_active IP Right Cessation
- 2014-03-04 US US14/773,076 patent/US10004712B2/en not_active Expired - Fee Related
- 2014-03-04 KR KR1020157027036A patent/KR20150138217A/ko not_active Application Discontinuation
- 2014-03-04 TW TW103107195A patent/TW201440747A/zh unknown
- 2014-03-04 EP EP14714768.0A patent/EP2964191A1/en not_active Withdrawn
- 2014-03-05 AR ARP140100718A patent/AR095020A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2964191A1 (en) | 2016-01-13 |
| TW201440747A (zh) | 2014-11-01 |
| GB201303796D0 (en) | 2013-04-17 |
| AU2014224449B2 (en) | 2018-04-19 |
| RU2668527C2 (ru) | 2018-10-01 |
| RU2015138950A (ru) | 2017-04-07 |
| AU2014224449A1 (en) | 2015-09-24 |
| US10004712B2 (en) | 2018-06-26 |
| WO2014135855A1 (en) | 2014-09-12 |
| JP2016511045A (ja) | 2016-04-14 |
| KR20150138217A (ko) | 2015-12-09 |
| CN105188665A (zh) | 2015-12-23 |
| US20160015668A1 (en) | 2016-01-21 |
| MX2015011394A (es) | 2016-06-06 |
| BR112015021306A2 (pt) | 2017-07-18 |
| CA2903289A1 (en) | 2014-09-12 |
| JP6337027B2 (ja) | 2018-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2016005320A (es) | Formulaciones y mã‰todos de tratamiento con queratina | |
| MX2017013983A (es) | Uso de agentes activos durante tratamientos quimicos. | |
| BR112018000734A2 (pt) | composições tópicas retinoicas | |
| AR097953A1 (es) | Material de relleno tratado, composiciones que lo contienen y artículos preparados a partir del mismo | |
| CL2018000033A1 (es) | Composición para destapar una nariz tapada que tiene actividad antiviral. | |
| PE20171334A1 (es) | Formulacion en polvo nasal para el tratamiento de hipoglicemia | |
| EP4249431A3 (en) | Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions | |
| EA201592073A1 (ru) | Фармацевтические композиции, содержащие коллаген и гиалуронат натрия | |
| AR082155A1 (es) | Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido | |
| CL2015002817A1 (es) | Formulación del l-5-metiltetrahidrofolato de calcio amorfo (l-5-mthf-ca). | |
| UA113962C2 (xx) | Фармацевтична композиція, яка містить апоморфін як активний інгредієнт | |
| RS54131B1 (en) | NEW PHARMACEUTICAL FORMULATION FOR FUNGAL INFECTION TREATMENT | |
| BR112016029996A2 (pt) | utilização cosmética, composição e método cosmético para tratar os odores corporais | |
| PH12017501304A1 (en) | Levodopa and carbidopa intestinal gel and method of use | |
| AR095020A1 (es) | Condón | |
| BR112013011064A2 (pt) | uso cosmético nutracêutico ou oral e processo de tratamento cosmético oral | |
| BR112018001002A2 (pt) | composição antimicrobiana com eficácia contra endósporos | |
| WO2019099860A3 (en) | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing | |
| MX2016014261A (es) | Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis. | |
| BR112014014471A2 (pt) | método, dispositivo optoeletricamente ativo e dispositivo fotovoltaico | |
| CR20160116A (es) | Método para tratar onicomicosis con hidroxipropil quitasano | |
| RU2015141637A (ru) | Способ обработки костной полости после некрсеквестрэктомии | |
| UY36598A (es) | Composición para el tratamiento de neuropatías y/o dolor neuropático | |
| RU2014125665A (ru) | Способ наружного лечения микозов кожи | |
| PL413884A1 (pl) | Sposób izolowania śluzu ślimaka, kompozycja i zastosowanie śluzu ślimaka Limax maximus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |